Akzo Nobel subsidiary Organon and Schering have abandonned their joint project to develop a new contraceptive for men. Organon said that the new method, consisting of an annual implant and quarterly injections,would probably not lead to a large take-up rate.
Thank you for donating to DutchNews.nl.
We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.Make a donation